Role of home monitoring with iCare ONE rebound tonometer in glaucoma patients management

作     者：Eldar Rosenfeld Gilad Rabina Dana Barequet Michael Mimouni Naomi Fischer Shimon Kurtz 

作者机构：Department of OphthalmologyTel Aviv Sourasky Medical CenterAffiliated to the Sackler Faculty of MedicineTel Aviv UniversityTel Aviv 64239Israel Department of OphthalmologyRambam Health Care CarmpusAffiliated to Ruth Rappaport Faculty of MedicineTechnion-lsrael Institute of TechnologyHaifa 3109601Israel 

出 版 物：《International Journal of Ophthalmology(English edition)》 (国际眼科杂志（英文版）)

年 卷 期：2021年第14卷第3期

页      面：405-408页

核心收录：

学科分类：1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

主　　题：glaucoma intraocular pressure home monitoring iCare ONE peak 

摘      要：AIM: To evaluate intraocular pressure(IOP) measurements and fluctuations using the i Care ONE rebound tonometer(RT-ONE), during home monitoring, in diagnosed and suspected glaucoma ***: A retrospective case series of consecutive patients with known glaucoma or glaucoma suspects who were followed-up and treated between January 2016 and January 2017. The study included 80 eyes of 40 patients with a mean age of 59.1±14.6 y(range, 24-78). All patients have undergone 4-5 d of IOP home monitoring with RT-ONE at morning, noon, afternoon, and night ***: Baseline mean IOP, as measured in the clinic(8 a.m.-12 p.m.), was 17.4±5.1 mm Hg, compared to RT-ONE home monitoring mean IOP of 15.6±4.1 mm Hg(P=0.002). Mean IOP was significantly lower at noon, afternoon and night times compared to clinic measured IOP and morning measurements(P=0.005). IOP peak measured during home monitoring was significantly higher compared to the clinic measured IOP(21.3±5.6 mm Hg and 17.4±5.1 mm Hg, P0.001). IOP peaks during home monitoring demonstrated a majority of 47 peaks during morning measurements, compared to 23 at noon, 19 at afternoon and only 12 at night(P0.001). The home monitoring results led to treatment modification of 44 eyes(55%), treatment regime was insufficient for 40(50%) ***: Home monitoring IOP with RT-ONE can provide good assessment of mean IOP, IOP fluctuations and peaks throughout the hours of the day, which lead to an accurate treatment for glaucoma patients.